Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Whole-genome sequencing

Enhancing childhood cancer targetability

Nature Cancer volume 4, pages 153–155 (2023)Cite this article

Subjects

Overall survival for children with rare, relapsed, metastatic and/or refractory cancers has remained unacceptably low over the past four decades. A new precision oncology study introduces an integrative germline and somatic sequencing approach that could breach this impasse to advance cures for children with cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Integrative germline and somatic sequencing and data analysis expands the repertoire of clinically actionable targets in pediatric cancer.

References

  1. American Cancer Society. Key statistics for childhood cancers. https://go.nature.com/3Bc2pQs (accessed 14 September 2022).

  2. American Cancer Society. Childhood 5-year survival. https://go.nature.com/3FsrE3I (accessed 14 September 2022).

  3. Villani, A. et al. Nat. Cancer https://doi.org/10.1038/s43018-022-00474-y (2022).

  4. Alexandrov, L. B. et al. Nature 578, 94–101 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Aronson, M. et al. J. Med. Genet. 59, 318–327 (2022).

    Article  CAS  PubMed  Google Scholar 

  6. Mueller, S. et al. Int. J. Cancer 145, 1889–1901 (2019).

    CAS  PubMed  Google Scholar 

  7. Rusch, M. et al. Nat. Commun. 9, 3962 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kline, C. et al. Clin. Cancer Res. https://doi.org/10.1158/1078-0432.CCR-22-0803 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Chang, W. et al. Clin. Cancer Res. 22, 3810–3820 (2010).

    Article  Google Scholar 

  10. Worst, B. C. et al. Eur. J. Cancer 65, 91–101 (2016).

    Article  PubMed  Google Scholar 

  11. Den Boer, M. L. et al. Lancet Oncol. 10, 125–134 (2009).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    Ammar S. Naqvi & Jo Lynne Rokita

  2. Division of Neurosurgery, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    Ammar S. Naqvi & Jo Lynne Rokita

  3. Department of Bioinformatics and Health Informatics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    Ammar S. Naqvi & Jo Lynne Rokita

Authors
  1. Ammar S. Naqvi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jo Lynne Rokita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jo Lynne Rokita.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Naqvi, A.S., Rokita, J.L. Enhancing childhood cancer targetability. Nat Cancer 4, 153–155 (2023). https://doi.org/10.1038/s43018-022-00472-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43018-022-00472-0

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer